Management and Anticoagulation Treatment of Non-Valvular Atrial Fibrillation in Elderly Patients: The Dali Study

References

• Du X, Guo L, Xia S, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China. Heart. 2021;107(7):535–541. doi:10.1136/heartjnl-2020-317915
   PubMed Web of Science ®Google Scholar
• Chang SS, Dong JZ, Ma CS, et al. Current status and time trends of oral anticoagulation use among Chinese patients with nonvalvular atrial fibrillation: the Chinese Atrial Fibrillation Registry Study. Stroke. 2016;47(7):1803–1810. doi:10.1161/STROKEAHA.116.012988
   PubMed Web of Science ®Google Scholar
• Shi S, Tang Y, Zhao Q, et al. Prevalence and risk of atrial fibrillation in China: a national cross-sectional epidemiological study. Lancet Reg Health West Pac. 2022;23:100439. doi:10.1016/j.lanwpc.2022.100439
   PubMedGoogle Scholar
• Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–221. doi:10.1177/1747493019897870
   PubMed Web of Science ®Google Scholar
• Guo Y, Kotalczyk A, Imberti JF, et al. Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. Eur Heart J Qual Care Clin Outcomes. 2022;8(6):651–658. doi:10.1093/ehjqcco/qcab057
   PubMed Web of Science ®Google Scholar
• Westerman S, Wenger N. Gender differences in atrial fibrillation: a review of epidemiology, management, and outcomes. Curr Cardiol Rev. 2019;15(2):136–144. doi:10.2174/1573403X15666181205110624
   PubMed Web of Science ®Google Scholar
• Li LH, Sheng CS, Hu BC, et al. The prevalence, incidence, management and risks of atrial fibrillation in an elderly Chinese population: a prospective study. BMC Cardiovasc Disord. 2015;15(1):31. doi:10.1186/s12872-015-0023-3
   PubMedGoogle Scholar
• Guo Y, Kotalczyk A, Imberti JF, et al. Oral anticoagulation improves survival in very elderly Chinese patient s with atrial fibrillation: a report from the Optimal Thromboprophylax is in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) reg istry. Int J Stroke. 2022;17(6):661–668. doi:10.1177/17474930211046743
   PubMed Web of Science ®Google Scholar
• Gutierrez C, Blanchard DG. Diagnosis and treatment of atrial fibrillation. Am Fam Physician. 2016;94(6):442–452.
   PubMed Web of Science ®Google Scholar
• Bjorck S, Palaszewski B, Friberg L, et al. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke. 2013;44(11):3103–3108. doi:10.1161/STROKEAHA.113.002329
   PubMed Web of Science ®Google Scholar
• Bansal N, Zelnick LR, An J, et al. Incident atrial fibrillation and risk of dementia in a diverse, community-based population. J Am Heart Assoc. 2023;12(6):e028290. doi:10.1161/JAHA.122.028290
   PubMed Web of Science ®Google Scholar
• Rouch L, Xia F, Bahorik A, et al. Atrial fibrillation is associated with greater risk of dementia in older veterans. Am J Geriatr Psychiatry. 2021;29(11):1092–1098. doi:10.1016/j.jagp.2021.02.038
   PubMed Web of Science ®Google Scholar
• Kim D, Yang PS, Yu HT, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort. Eur Heart J. 2019;40(28):2313–2323. doi:10.1093/eurheartj/ehz386
   PubMed Web of Science ®Google Scholar
• Steensig K, Olesen KKW, Thim T, et al. Should the presence or extent of coronary artery disease be quantified in the CHA2DS2-VASc score in atrial fibrillation? A report from the Western Denmark Heart Registry. Thromb Haemost. 2018;118(12):2162–2170. doi:10.1055/s-0038-1675401
   PubMed Web of Science ®Google Scholar
• Middeldorp ME, Ariyaratnam JP, Kamsani SH, et al. Hypertension and atrial fibrillation. J Hypertens. 2022;40(12):2337–2352. doi:10.1097/HJH.0000000000003278
   PubMed Web of Science ®Google Scholar
• Aune D, Feng T, Schlesinger S, et al. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. J Diabetes Complications. 2018;32(5):501–511. doi:10.1016/j.jdiacomp.2018.02.004
   PubMed Web of Science ®Google Scholar
• Pathak RK, Abhilash SP, Hendriks JM. A team-based approach toward risk factors of atrial fibrillation. Card Electrophysiol Clin. 2021;13(1):257–262. doi:10.1016/j.ccep.2020.11.008
   PubMedGoogle Scholar
• Huxley RR, Lopez FL, Folsom AR, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123(14):1501–1508. doi:10.1161/CIRCULATIONAHA.110.009035
   PubMed Web of Science ®Google Scholar
• Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol. 2014;64(3):281–289. doi:10.1016/j.jacc.2014.03.048
   PubMed Web of Science ®Google Scholar
• Aune D, Sen A, Schlesinger S, et al. Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2017;32(3):181–192. doi:10.1007/s10654-017-0232-4
   PubMed Web of Science ®Google Scholar
• Ragbaoui Y, Chehbouni C, Hammiri AE, et al. Epidémiologie de l’association fibrillation atriale et insuffisance cardiaque [Epidemiology of the relationship between atrial fibrillation and heart failure]. Pan Afr Med J. 2017;26:116. French. doi:10.11604/pamj.2017.26.116.11470
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Furberg CD, Psaty BM, et al. Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation. 2008;118(8):800–807. doi:10.1161/CIRCULATIONAHA.108.785626
   PubMed Web of Science ®Google Scholar
• Kannel WB, Abbott RD, Savage DD, et al. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J. 1983;106(2):389–396. doi:10.1016/0002-8703(83)90208-9
   PubMed Web of Science ®Google Scholar
• Aronow WS, Ahn C, Mercando AD, et al. Correlation of atrial fibrillation, paroxysmal supraventricular tachycardia, and sinus rhythm with incidences of new coronary events in 1359 patients, mean age 81 years, with heart disease. Am J Cardiol. 1995;75(2):182–184. doi:10.1016/S0002-9149(00)80074-0
   PubMed Web of Science ®Google Scholar
• Soliman EZ, Safford MM, Muntner P, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014;174(1):107–114. doi:10.1001/jamainternmed.2013.11912
   PubMed Web of Science ®Google Scholar
• Liang F, Wang Y. Coronary heart disease and atrial fibrillation: a vicious cycle. Am J Physiol Heart Circ Physiol. 2021;320(1):H1–H12. doi:10.1152/ajpheart.00702.2020
   PubMed Web of Science ®Google Scholar
• Wibawa K, Dewangga R, Nastiti KS, et al. Prior statin use and the incidence of in-hospital arrhythmia in acute coronary syndrome: a systematic review and meta-analysis. Indian Heart J. 2023;75(1):9–16. doi:10.1016/j.ihj.2023.01.004
   PubMedGoogle Scholar
• Manolis AJ, Poulimenos LE, Ambrosio G, et al. Medical treatment of stable angina: a tailored therapeutic approach. Int J Cardiol. 2016;220:445–453. doi:10.1016/j.ijcard.2016.06.150
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053
   PubMed Web of Science ®Google Scholar
• Lip GY. Implications of the CHA2DS2-VASc and HAS-BLED scores for thromboprophylaxis in atrial fibrillation. Am J Cardiol. 2011;124:111–114.
   Google Scholar
• Levy S. Classification system of atrial fibrillation. Curr Opin Cardiol. 2000;15(1):54–57. doi:10.1097/00001573-200001000-00007
   PubMed Web of Science ®Google Scholar
• Caraballo C, Desai NR, Mulder H, et al. Clinical implications of the New York Heart Association Classification. J Am Heart Assoc. 2019;8(23):e014240. doi:10.1161/JAHA.119.014240
   PubMed Web of Science ®Google Scholar
• Siu C-W, Tse H-F. Net clinical benefit of warfarin therapy in elderly Chinese patients w ith atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7(2):300–306. doi:10.1161/CIRCEP.113.000858
   PubMed Web of Science ®Google Scholar
• Guo Y, Kotalczyk A, Imberti JF, et al. Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. Eur Heart J Qual Care Clin Outcomes. 2023;9(2):169–176. doi:10.1093/ehjqcco/qcab054
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang H, Kotalczyk A, et al. One-year follow-up results of the optimal thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry. J Arrhythm. 2021;37(5):1227–1239. doi:10.1002/joa3.12608
   PubMed Web of Science ®Google Scholar
• Yu Z, Yu L, Shan C. Trends of ambulatory oral anticoagulant prescription in five major cities of China, 2012–2017. BMC Health Serv Res. 2020;20(1):209. doi:10.1186/s12913-020-5072-3
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang Y, Liao X, et al. Anticoagulation therapy for non-valvular atrial fibrillation: a mini-review. Front Med. 2020;7:350. doi:10.3389/fmed.2020.00350
   Web of Science ®Google Scholar
• Aktan A, Güzel T, Aslan B, et al. Comparison of the real-life clinical outcomes of warfarin with effective time in therapeutic range and non-vitamin K antagonist oral anticoagulants: insight from the AFTER-2 trial. Kardiol Pol. 2023;81(2):132–140. doi:10.33963/KP.a2022.0287
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Shah J, Essebag V, et al. Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol. 2006;97(4):538–543. doi:10.1016/j.amjcard.2005.09.086
   PubMed Web of Science ®Google Scholar
• DeWilde S, Carey IM, Emmas C, et al. Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart. 2006;92(8):1064–1070. doi:10.1136/hrt.2005.069492
   PubMed Web of Science ®Google Scholar
• Shang L, Zhang Y, Zhao Y, et al. Contemporary oral anticoagulant therapy of patients with atrial fibrillation in China: status, obstacles, and strategies for improvement. Biosci Trends. 2022;16(5):317–329. doi:10.5582/bst.2022.01278
   PubMedGoogle Scholar
• Güzel T, Aktan A, Kılıç R, et al. Oral anticoagulant use and long-term follow-up results in patients with non-valvular atrial fibrillation in Turkey AFTER-2 study. Anatol J Cardiol. 2022;26(7):567–576. doi:10.5152/AnatolJCardiol.2022.1597
   PubMed Web of Science ®Google Scholar
• Batta A, Hatwal J, Batta A, et al. Atrial fibrillation and coronary artery disease: an integrative review focusing on therapeutic implications of this relationship. World J Cardiol. 2023;15(5):229–243. doi:10.4330/wjc.v15.i5.229
   PubMed Web of Science ®Google Scholar
• Fanaroff AC, Li S, Marquis-Gravel G, et al. Atrial fibrillation and coronary artery disease: a long-term perspective on the need for combined antithrombotic therapy. Circ Cardiovasc Interv. 2021;14(12):e011232. doi:10.1161/CIRCINTERVENTIONS.121.011232
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Kimura K, Yasuda S, et al. Antithrombotic therapy for atrial fibrillation and coronary artery disease in patients with prior atherothrombotic disease: a post hoc analysis of the AFIRE trial. J Am Heart Assoc. 2021;10(21):e020907. doi:10.1161/JAHA.121.020907
   PubMed Web of Science ®Google Scholar
• Angiolillo DJ, Bhatt DL, Cannon CP, et al. Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American Perspective: 2021 update. Circulation. 2021;143(6):583–596. doi:10.1161/CIRCULATIONAHA.120.050438
   PubMed Web of Science ®Google Scholar